FIELD: medicine.
SUBSTANCE: invention describes a method of gradually optimising a dose of 5-FU administered by continuous infusion to the patients being treated with the FOLFOX or similar regime, on the basis of the plasma concentration of 5-FU measured during the preceding continuous infusion of 5-FU, and described in the given application of the decision procedure. The present invention also refers to a method of treating a patient with cancer wherein the dose of 5-FU administered into continuous infusion in each FOLFOX cycle or similar therapeutic cycle, optimised with using the decision procedure in accordance with the invention.
EFFECT: gradually optimising the doses of 5-FU.
14 cl, 3 dwg, 8 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPTIMISING INDIVIDUAL DOSES OF 5-FLUORURACIL IN FOLFIRI REGIMEN | 2008 |
|
RU2496499C2 |
| ADMINISTRATION OF MULTIPLE BOLUSES [6R]-MTHF IN CHEMOTHERAPY BASED ON 5-FLUOROURACIL | 2018 |
|
RU2762596C2 |
| [6R]-MTHF-EFFECTIVE FOLATE ALTERNATIVE IN CHEMOTHERAPY BASED ON 5-FLUOROURACIL | 2018 |
|
RU2763934C2 |
| METHODS FOR TREATMENT OF COLORECTAL AND METASTATIC COLORECTAL CANCER | 2019 |
|
RU2779535C2 |
| TREATMENT OF STOMACH CANCER USING COMBINATION TYPES OF THERAPY CONTAINING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL (AND LEUCOVORIN) | 2017 |
|
RU2761953C2 |
| METHODS FOR INCREASING LEVEL OF 2'-DEOXYURIDINE (DURD) IN PLASMA AND INHIBITING THYMIDYLATE SYNTHASE | 2018 |
|
RU2775781C2 |
| METHODS OF TREATING PANCREAS CANCER USING COMBINATION THERAPY INCLUDING LIPOSOMAL IRINOTECAN | 2013 |
|
RU2808427C2 |
| METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPY COMPRISING LIPOSOMAL IRINOTECAN | 2013 |
|
RU2663450C2 |
| THERAPEUTIC COMBINATIONS CONTAINING INHIBITOR OF POLY(ADP-RIBOSE)POLYMERASE | 2005 |
|
RU2361592C2 |
| METHOD OF TREATING CANCER WITH DLL4 ANTAGONIST AND CHEMOTHERAPEUTIC AGENT | 2010 |
|
RU2571220C2 |
